PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsReviewsTV Review: Panorama — Inside Britain's Fertility Business

BioNews

TV Review: Panorama — Inside Britain's Fertility Business

Published 5 December 2016 posted in Reviews and appears in BioNews 880

Author

Dr Jane Currie

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.

Panorama's investigation into the use of 'add-ons' in private fertility clinics is a novel mixture of undercover journalism and a high-quality systematic review of the clinical evidence...


Panorama – Inside Britain's Fertility Business

BBC One, 28 November 2016

Presented by Deborah Cohen


'We believe what doctors tell us … this is a doctor that holds my happiness in his hands.'

This woman, speaking at the start of Panorama's 'Inside Britain's Fertility Business', captures the vulnerability of patients undergoing private fertility care and their relationship with the doctors they pay to care for them. First broadcast on 28 November, Panorama explores the murky world of 'add-ons' in private fertility clinics, using a novel mixture of undercover journalism combined with a high-quality systematic review of the clinical evidence.

'Add-ons' refers to the practice of offering additional tests, procedures and treatments for IVF patients. Panorama asks if there is sufficient evidence for these add-ons, which are often expensive, that would justify their use.

The programme is engagingly presented by Deborah Cohen, a journalist and associate editor at the BMJ. She explains that there are around 50,000 women undergoing fertility treatment annually, of whom 60 percent are treated in the private sector. Only a quarter of IVF procedures are successful overall, and odds decrease with age.

Cohen brings the problem to life with powerful patient narratives. One woman, who says 'we don't have oodles of cash coming in', spent £45,000 on fertility treatments, and she is not alone in this scale of spending. Another couple, who spent £23,000, describe how they were sold add-ons of Natural Killer (NK) cell testing and treatment for high levels. They were led to believe this would increase their chance of IVF success.

Panorama makes an undercover visit to the Zita West Clinic in London to explore NK cell add-on use. The undercover couple are advised to have blood NK cell levels tested. They are subsequently informed that levels are raised and are advised to have treatment with intravenous intralipid – a mixture of egg and soya – to improve pregnancy success. The doctor quotes statistics that in women with six failed cycles of IVF, a subsequent cycle's success rate is increased from nine percent to 45 percent with intralipid. Despite some probing from the couple, he does not offer any caution about the treatment other than the risk of allergy to ingredients. However, Panorama reports that these figures are based on low-quality research.

Such real-life stories are interwoven with the tale of the development of a systematic review on this topic – itself an interesting story. I didn't realise until quite late on that the programme led to the review and publication of the data in the prestigious BMJ, despite interviews with Professor Carl Heneghan and his team at the Oxford University Centre for Evidence-Based Medicine, who carried it out.

The systematic review found no high-quality evidence in support of add-ons. For one add-on (preimplantation genetic screening or PGS) there was data suggesting it decreases pregnancy rates – or at least an older version of the treatment does.

Initially, I thought Panorama was accusing some unscrupulous clinics of offering expensive add-ons that have been proven not to work. However, aside from PGS the problem is more nuanced. The issue is a lack of evidence for their effectiveness. Professor Robert Winston is interviewed about the practice and hits the nail on the head when he states that 'good trials have not been done'.

A potential argument in defence of the fertility clinics is that, until the publication of a systematic review, the quality of evidence for a supporting add-on has not been well analysed. However, Panorama interviews experts who rubbish the scientific ideas underlying some of these add-ons – such as Professor Ashley Moffett, who studies NK cells at Cambridge University. Talking about the inappropriateness of blood NK cell testing to analyse uterine NK cells, she states: 'If you wanted to measure the number of black cabs in Trafalgar Square you do not measure the number of red minicabs on the M25.'

It is a medical truism that lack of evidence of effectiveness is not, in itself, evidence of ineffectiveness. Medicine is full of examples of practice that are not supported by high-level evidence. What Panorama emphasises is the vulnerability of patients and the large sums of money involved, and asks whether these combine to alter a doctor's behaviour in recommending treatments. Patients need to understand where treatments are experimental and whether there is any evidence to support their use; the fascinating filming at the fertility show, where private fertility clinics drum up business, confirms this does not always happen.

As a clinician, I found the issue of informed consent in private practice intriguing. Doctors practising in the UK's NHS are not used to dealing with overt financial conflicts of interest. However, in private practice there is a real risk that a doctor may offer a treatment a patient does not need to increase revenue. How can the patient, and the doctor, be sure that this is not happening?

A question the documentary does not tackle is why there is a lack of evidence. Is there no funding for large-scale trials of this nature? Do patients choose not to participate in them? A randomised controlled trial of an intervention requires there to be clinical equipoise, in that there is no evidence either for or against a procedure. It may be difficult to persuade a desperate patient of this position, or a doctor who believes in the procedure. However, this is exactly the situation where high-quality trials are most required.

This Panorama episode is hugely important for combining traditional documentary journalism with a trustworthy systematic review. Hopefully, future patients of the clinics involved will also benefit from better information. It is worth watching, both for healthcare practitioners to reflect on their processes of informed consent, and to empower patients who use private fertility services. Those with an interest in the potential privatisation of the NHS would also benefit.

Sources and References

  • 28/11/2016
    BMJ
    Lack of evidence for interventions offered in UK fertility centres

Related Articles

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Reviews
5 November 2018 • 4 minutes read

TV Review: Inside Out West - 29.10.18 (BBC)

by Dr Eleanor Taylor

Fertility treatment is big business within the UK. The ever-increasing demand for fertility services combined with the dwindling availability of NHS-funding for fertility treatment has created a booming 'fertility industry'...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
17 September 2018 • 5 minutes read

Battle-worn: Setting up a multi-centre, randomised, controlled trial in the UK

by Professor Roy Homburg and 1 others

Why has clinical evidence on IVF 'add-ons' not been forthcoming?...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
24 July 2017 • 1 minute read

The fertility sector has a problem when it comes to IVF add-ons

by BioNews

The fourth in a series of videos filmed at the Progress Educational Trust's recent public debate 'Fertility Treatment Add-Ons: Do They Add Up?'...

PET BioNews
Comment
26 June 2017 • 1 minute read

Responsible innovation and IVF add-ons - it's time for the fertility sector to step up

by BioNews

The second in a series of videos filmed at the Progress Educational Trust's recent public debate 'Fertility Treatment Add-Ons: Do They Add Up?'...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
19 June 2017 • 1 minute read

The fertility sector should lead the debate on IVF add-ons

by BioNews

The first in a series of videos filmed at the Progress Educational Trust's recent public debate 'Fertility Treatment Add-Ons: Do They Add Up?'...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
6 June 2016 • 3 minutes read

Australian documentary accuses IVF clinics of peddling false hope

by Dr Mary Yarwood

An Australian documentary has claimed that women over 40 are being misled about their chances of conceiving via IVF treatment when using their own eggs...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
23 May 2016 • 3 minutes read

Fertility specialists warn against unnecessary, expensive treatments

by Dr Lone Hørlyck

A number of fertility specialists have raised concerns over private clinics offering expensive 'add-on' treatments to patients, sometimes without sufficient evidence of their effectiveness...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
12 January 2015 • 6 minutes read

The good, the bad and the ugly: compassion and corruption in the commercial baby business

by Dr Ëlo Luik

Are business and medicine hopelessly intertwined in fertility care, at (quite literally) the expense of the patient?...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Video Review: Prenatal Genetic Testing — Making an Informed Decision

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels


easyfundraising
amazon

This month in Reviews

  • Popular
  • Recent
13 November 2023 • 3 minutes read

TV Review: Stranger in My Family

6 November 2023 • 4 minutes read

Exhibition Review: Real Families – Stories of change

30 October 2023 • 3 minutes read

TV Review: DNA – Series two

16 October 2023 • 5 minutes read

Book Review: Patient 1 – Forgetting and finding myself

9 October 2023 • 4 minutes read

Podcast Review: The Gift – Fraud

27 November 2023 • 4 minutes read

Podcast Review: The Gift – Health

20 November 2023 • 5 minutes read

Event Review: The Science of Integrated Human Embryo Models

20 November 2023 • 4 minutes read

Podcast Review: The Gift – Mistakes

13 November 2023 • 3 minutes read

TV Review: Stranger in My Family

6 November 2023 • 4 minutes read

Exhibition Review: Real Families – Stories of change

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2023 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2023 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856